Halper Sadeh LLC Launches Investigations into ONCO, WAT, and XAGE Shareholder Concerns

Shareholder Investigations: Halper Sadeh LLC Probes ONCO, WAT, and XAGE on Behalf of Investors

Halper Sadeh LLC, a law firm recognized for representing investors' rights, has unveiled its investigation into three notable companies—Onconetix, Inc. (NASDAQ: ONCO), Waters Corporation (NYSE: WAT), and Longevity Health Holdings, Inc. (NASDAQ: XAGE). This inquiry has arisen due to potential infractions against federal securities laws and possible breaches of fiduciary duties owed to shareholders in connection with significant merger activities involving these firms.

Onconetix, Inc. (NASDAQ: ONCO)

The proposed merger between Onconetix, Inc. and Ocuvex Therapeutics, Inc. is of particular interest. Upon completion of this transaction, existing Onconetix shareholders are anticipated to own approximately 10% of the combined entity. Halper Sadeh LLC is actively reaching out to Onconetix shareholders to discuss their rights and potential options in light of the merger's implications.
This investigation aims to ensure that shareholders are fully informed and adequately represented during this business transition.

Waters Corporation (NYSE: WAT)

Similarly, Waters Corporation is undergoing a merger with BD and Company's Biosciences Diagnostic Solutions business. Following the finalization of this deal, current Waters shareholders are expected to hold around 60.8% of the newly formed corporation. Halper Sadeh LLC is focusing on evaluating the terms of this merger and the fiduciary responsibilities of the involved parties to their investors. Shareholders of Waters Corporation are encouraged to make inquiries concerning their interests and rights moving forward.

Longevity Health Holdings, Inc. (NASDAQ: XAGE)

The scrutiny also extends to Longevity Health Holdings, Inc., which is merging with 20/20 BioLabs, Inc. This merger is projected to result in Longevity shareholders retaining an estimated 49.9% ownership stake in the merged entity. Given such significant changes, Halper Sadeh LLC aims to advocate for enhanced disclosure and fairness for shareholders throughout this process. Investors are advised to connect with the firm to understand their legal rights during the impending transition.

Legal Representation and Support

Halper Sadeh LLC emphasizes its commitment to advocating for shareholder rights, seeking improved terms or disclosures from the companies under investigation. This firm operates on a contingency fee basis, meaning investors will not incur upfront legal costs and can explore their options without financial risk.

In light of these investigations, Halper Sadeh LLC encourages shareholders from all three companies to reach out for free consultations to discuss their legal positions. They can contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] for more information.

Conclusion

In an ever-evolving financial landscape, staying informed and proactive is key for shareholders as corporate strategies shift through mergers and acquisitions. Investors who have concerns about their equity stakes in ONCO, WAT, or XAGE should not hesitate to utilize Halper Sadeh LLC’s expertise to ensure that their rights are protected and that they receive the full scope of potential benefits from their investments.

Halper Sadeh LLC has a track record of representing victims of securities fraud and corporate misbehavior, enabling reforms and financially recovering losses for investors globally. Remember, past victories do not guarantee future results, but informed action is a prudent strategy for navigating these complex waters.